266 related articles for article (PubMed ID: 1527228)
21. Serum levels of clomipramine and desmethylclomipramine and clinical improvement in panic disorder.
Marcourakis T; Gorenstein C; Ramos RT; da Motta Singer J
J Psychopharmacol; 1999; 13(1):40-4. PubMed ID: 10221358
[TBL] [Abstract][Full Text] [Related]
22. Clomipramine, a better reference drug for panic/agoraphobia. I. Effectiveness comparison with imipramine.
Gentil V; Lotufo-Neto F; Andrade L; Cordás T; Bernik M; Ramos R; Maciel L; Miyakawa E; Gorenstein C
J Psychopharmacol; 1993 Jan; 7(4):316-24. PubMed ID: 22290994
[TBL] [Abstract][Full Text] [Related]
23. The clinical effect of clomipramine in chronic idiopathic pain disorder revisited using the Spielberger State Anxiety Symptom Scale (SSASS) as outcome scale.
Bech P; Gormsen L; Loldrup D; Lunde M
J Affect Disord; 2009 Dec; 119(1-3):43-51. PubMed ID: 19349078
[TBL] [Abstract][Full Text] [Related]
24. A double-blind crossover comparison of clomipramine and desipramine in the treatment of panic disorder.
Sasson Y; Iancu I; Fux M; Taub M; Dannon PN; Zohar J
Eur Neuropsychopharmacol; 1999 Mar; 9(3):191-6. PubMed ID: 10208287
[TBL] [Abstract][Full Text] [Related]
25. Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder. Collaborative Paroxetine Panic Study Investigators.
Lecrubier Y; Judge R
Acta Psychiatr Scand; 1997 Feb; 95(2):153-60. PubMed ID: 9065681
[TBL] [Abstract][Full Text] [Related]
26. Paroxetine, clomipramine, and cognitive therapy in the treatment of panic disorder.
Bakker A; van Dyck R; Spinhoven P; van Balkom AJ
J Clin Psychiatry; 1999 Dec; 60(12):831-8. PubMed ID: 10665629
[TBL] [Abstract][Full Text] [Related]
27. Treatment of panic disorder.
Cassano GB; Toni C; Musetti L
Adv Biochem Psychopharmacol; 1992; 47():449-60. PubMed ID: 1509926
[No Abstract] [Full Text] [Related]
28. The Galway Study of Panic Disorder. I: Clomipramine and lofepramine in DSM III-R panic disorder: a placebo controlled trial.
Fahy TJ; O'Rourke D; Brophy J; Schazmann W; Sciascia S
J Affect Disord; 1992 May; 25(1):63-75. PubMed ID: 1624646
[TBL] [Abstract][Full Text] [Related]
29. Pretreatment anxiety level as differential predictor in outpatients with panic disorder.
Scheibe G; Nutzinger D; Buller R; Walther AU
Arzneimittelforschung; 1992 Sep; 42(9):1090-4. PubMed ID: 1445474
[TBL] [Abstract][Full Text] [Related]
30. [Patients with panic disorder: a 5-year follow-up study].
León CA; Arévalo W; Gaviria LF; Leon A
Acta Psiquiatr Psicol Am Lat; 1992 Dec; 38(4):279-88. PubMed ID: 1341123
[TBL] [Abstract][Full Text] [Related]
31. Treatment of panic disorder in older adults: a pilot study comparison of alprazolam, imipramine, and placebo.
Sheikh JI; Swales PJ
Int J Psychiatry Med; 1999; 29(1):107-17. PubMed ID: 10376237
[TBL] [Abstract][Full Text] [Related]
32. Lactate-induced anxiety after imipramine and diazepam treatment.
Pohl R; Balon R; Berchou R; Lycaki H
Anxiety; 1994; 1(2):54-63. PubMed ID: 9160549
[TBL] [Abstract][Full Text] [Related]
33. Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis.
Boyer W
Int Clin Psychopharmacol; 1995 Mar; 10(1):45-9. PubMed ID: 7622804
[TBL] [Abstract][Full Text] [Related]
34. A clinical trial of clomipramine and diazepam in the treatment of phobic and obsessional illness.
Waxman D
J Int Med Res; 1977; 5 Suppl 5():99-110. PubMed ID: 598611
[TBL] [Abstract][Full Text] [Related]
35. Clomipramine for panic disorder: I. The first 10 weeks of a long-term comparison with imipramine.
Cassano GB; Petracca A; Perugi G; Nisita C; Musetti L; Mengali F; McNair DM
J Affect Disord; 1988; 14(2):123-7. PubMed ID: 2966825
[TBL] [Abstract][Full Text] [Related]
36. Comparison of aerobic exercise, clomipramine, and placebo in the treatment of panic disorder.
Broocks A; Bandelow B; Pekrun G; George A; Meyer T; Bartmann U; Hillmer-Vogel U; Rüther E
Am J Psychiatry; 1998 May; 155(5):603-9. PubMed ID: 9585709
[TBL] [Abstract][Full Text] [Related]
37. A controlled, prospective, 1-year trial of citalopram in the treatment of panic disorder.
Lepola UM; Wade AG; Leinonen EV; Koponen HJ; Frazer J; Sjödin I; Penttinen JT; Pedersen T; Lehto HJ
J Clin Psychiatry; 1998 Oct; 59(10):528-34. PubMed ID: 9818634
[TBL] [Abstract][Full Text] [Related]
38. A dose-finding and discontinuation study of clomipramine in panic disorder.
Lotufo-Neto F; Bernik M; Ramos RT; Andrade L; Gorenstein C; Cordas T; Melo M; Gentil V
J Psychopharmacol; 2001 Mar; 15(1):13-7. PubMed ID: 11277602
[TBL] [Abstract][Full Text] [Related]
39. Clomipramine, a better reference drug for panic/agoraphobia. II. Psychomotor and cognitive effects.
Marcourakis T; Gorenstein C; Gentil V
J Psychopharmacol; 1993 Jan; 7(4):325-30. PubMed ID: 22290995
[TBL] [Abstract][Full Text] [Related]
40. A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Collaborative Paroxetine Panic Study Investigators.
Lecrubier Y; Bakker A; Dunbar G; Judge R
Acta Psychiatr Scand; 1997 Feb; 95(2):145-52. PubMed ID: 9065680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
